Dr. Stuart Reeves, head of R&D and Embria Health Sciences in the Des Moines area, has coined a new term: Inflammaging.
The abstract describing this iskind of complex (click the Inflammaging link to read it in a PowerPoint format). But from what I make of it, the primary thesis is that aging in humans appears to be accompanied by a chronic overload of inflammation-inducing immune cells, e.g. cytokines.
Stuart works on Embria’s immune support supplement ingredient, EpiCor, helping coordinate scientific trials, reviewing the latest published literature on immune function and consulting companies who are using EpiCor in their supplement products.
The presence of pro-inflammatory cell activity as one ages begs the question: could the ability to manage such long-term inflammation make a difference in the aging process and in helping counter age-related diseases such as heart disease, arthritis, even cognitive conditions? If the immune system could maintain a healthier balance to offset chronic low-grade inflammation, what would happen?
The possibilities are fascinating.